21st February 2011
Since 1999, when GlaxoSmithKline’s (GSK) blockbuster diabetes drug Avandia (also known as Rosiglitazone) was approved by the FDA (US Food and Drug Administration), it has caused nothing more than a rollercoaster ride for the global pharmaceutical company...
Read >